WealthShield Partners LLC Sells 235 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

WealthShield Partners LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,868 shares of the exchange traded fund’s stock after selling 235 shares during the quarter. WealthShield Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $168,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in XBI. Howard Capital Management Group LLC grew its stake in shares of SPDR S&P Biotech ETF by 2.6% in the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of SPDR S&P Biotech ETF by 16.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,390 shares of the exchange traded fund’s stock worth $2,113,000 after buying an additional 2,997 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 4.1% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 118,563 shares of the exchange traded fund’s stock worth $11,714,000 after buying an additional 4,625 shares during the last quarter. Sicart Associates LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 3.9% in the 3rd quarter. Sicart Associates LLC now owns 5,303 shares of the exchange traded fund’s stock worth $524,000 after buying an additional 200 shares during the last quarter. Finally, Financial Advocates Investment Management purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $1,300,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $88.69 on Wednesday. The company’s 50-day moving average is $91.14 and its 200 day moving average is $95.92. The company has a market capitalization of $6.76 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.